Predictive relevance of miR‑34a, miR‑224 and miR‑342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy

  • Authors:
    • Vlastimil Kulda
    • Martin Svaton
    • Petr Mukensnabl
    • Kristyna Hrda
    • Pavel Dvorak
    • Zbynek Houdek
    • Katerina Houfkova
    • Radana Vrzakova
    • Vaclav Babuska
    • Milos Pesek
    • Martin Pesta
  • View Affiliations

  • Published online on: November 2, 2017     https://doi.org/10.3892/ol.2017.7337
  • Pages:592-599
Metrics: HTML 0 views | PDF 0 views
0

Abstract

Attributing to their pathophysiological role and stability in biological samples, microRNAs (miRNAs) have the potential to become valuable predictive markers for non‑small cell lung cancer (NSCLC). Samples of biopsy tissue constitute suitable material for miRNA profiling with the aim of predicting the effect of palliative chemotherapy. The present study group included 81 patients (74 males, 7 females, all smokers or former smokers) with the squamous cell carcinoma (SCC) histological subtype of NSCLC at a late stage (3B or 4). All patients received palliative chemotherapy based on platinum derivatives in combination with paclitaxel or gemcitabine. The expression of 17 selected miRNAs was measured by reverse transcription‑quantitative polymerase chain reaction in tumor tissue macrodissected from formalin‑fixed paraffin‑embedded (FFPE) tissue samples. To predict the effect of palliative chemotherapy, the association between gene expression levels and overall survival (OS) time was analyzed. From the 17 miRNAs of interest, low expression levels of miR‑342 and high expression levels of miR‑34a and miR‑224 were associated with a reduced OS time in subgroups of patients based on smoking status and treatment modality. Using cluster analysis, associations between combinations of miR‑34a, ‑224 and ‑342 expression levels with patient survival were identified. The present study revealed that patients with the simultaneous high expression of miR‑224 and ‑342 had a similar prognostic outcome to those with the low expression of miR‑224 and ‑342, which was significantly reduced, compared with patients exhibiting high expression of either miR‑224 or miR‑342 with low expression of the other. We hypothesize that the effect of a particular miRNA is dependent on the expression level of other members of the miRNA network. This finding appears to complicate survival analyses based on individual miRNAs as markers. In conclusion, the present study provides evidence that specific miRNAs were associated with OS time, which may be candidate predictors for the effectiveness of palliative treatment in SCC lung cancer patients. This objective can be better achieved by combining more markers together than by using individual miRNAs.

Related Articles

Journal Cover

January 2018
Volume 15 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Kulda, V., Svaton, M., Mukensnabl, P., Hrda, K., Dvorak, P., Houdek, Z. ... Pesta, M. (2018). Predictive relevance of miR‑34a, miR‑224 and miR‑342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy. Oncology Letters, 15, 592-599. https://doi.org/10.3892/ol.2017.7337
MLA
Kulda, V., Svaton, M., Mukensnabl, P., Hrda, K., Dvorak, P., Houdek, Z., Houfkova, K., Vrzakova, R., Babuska, V., Pesek, M., Pesta, M."Predictive relevance of miR‑34a, miR‑224 and miR‑342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy". Oncology Letters 15.1 (2018): 592-599.
Chicago
Kulda, V., Svaton, M., Mukensnabl, P., Hrda, K., Dvorak, P., Houdek, Z., Houfkova, K., Vrzakova, R., Babuska, V., Pesek, M., Pesta, M."Predictive relevance of miR‑34a, miR‑224 and miR‑342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy". Oncology Letters 15, no. 1 (2018): 592-599. https://doi.org/10.3892/ol.2017.7337